You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

List of Excipients in API sitagliptin hydrochloride oral

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing sitagliptin hydrochloride oral

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	ANHYDROUS CITRIC ACID	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	BUTYLATED HYDROXYANISOLE	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	EDETATE DISODIUM	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	HYDROXYETHYL CELLULOSE	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	METHYLPARABEN SODIUM	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	POLYSORBATE 80	2040-10-23
Azurity Pharmaceuticals Inc	BRYNOVIN	sitagliptin hydrochloride oral	24338-017	SODIUM CITRATE	2040-10-23
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for sitagliptin hydrochloride oral

Excipient focus: ANHYDROUS CITRIC ACID

sitagliptin hydrochloride oral drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BUTYLATED HYDROXYANISOLE

sitagliptin hydrochloride oral drug variants containing BUTYLATED HYDROXYANISOLE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing BUTYLATED HYDROXYANISOLE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: EDETATE DISODIUM

sitagliptin hydrochloride oral drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYETHYL CELLULOSE

sitagliptin hydrochloride oral drug variants containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN SODIUM

sitagliptin hydrochloride oral drug variants containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

sitagliptin hydrochloride oral drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CITRATE

sitagliptin hydrochloride oral drug variants containing SODIUM CITRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing SODIUM CITRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

sitagliptin hydrochloride oral drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Azurity Pharmaceuticals Inc	sitagliptin hydrochloride oral	24338-017
>Company	>Ingredient	>NDC

sitagliptin hydrochloride oral drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.